Back to Authors

Graff‐Radford, Neill R.

https://orcid.org/0000-0001-9847-9096

Mayo Clinic

Mayo Clinic

Citations 465

O4‐08‐02: Prevention of Postmenopausal Alzheimer's Disease and Cognitive Loss with Replacement Estrogen (PREPARE) Study Results
Sano, Mary , Luo, Xiaodong , Andrews, Howard, Andrews, Karen L., Bell, Karen L. , Graff‐Radford, Neill R. , Lucas, John A. , Rabins, Peter V., Bolla, Karen I., Mitsis, Effie, Jacobs, Diane M.

Alzheimer's & Dementia | October 26, 2010 | Volume: 6 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2010.08.055 Get It

P3‐193: The plasma Aβ42/Aβ40 ratio: A promising biomarker for cognitive decline
Weston, Andrea, Hou, Nanjiang, Graff‐Radford, Neill R. , Satterfield, Suzanne , Harris, Tamara B. , Kuller, Lewis H. , Ayonayon, Hilsa N., Dong, Jingzhong, Younkin, Linda H., Younkin, Steven G. , Yaffe, Kristine , Study, for the Health ABC, Simonsick, Eleanor Marie , Study, for the Health ABC

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_16 | Pages: No page available

10.1016/j.jalz.2010.05.1691 Get It

P2‐105: An informant‐based questionnaire for the differential diagnosis of dementia
Parfitt, Francine, Pao, Winnie, Ertekin‐Taner, Nilüfer , Graff‐Radford, Neill R. , Crook, Julia E.

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_11 | Pages: No page available

10.1016/j.jalz.2010.05.1152 Get It

P1‐098: Association of common KIBRA variants with episodic memory and Alzheimer risk
Ertekin‐Taner, Nilüfer , Hirpa, Meron, Nguyen, Thuy , Li, Ma, Zou, Fanggeng, Younkin, Steven G., Petersen, Ronald C. , Graff‐Radford, Neill R. , Pedraza, Otto , Burgess, Jeremy D. , Crook, Julia E. , Pankratz, V. Shane

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2010.05.646 Get It

P1‐067: Implications and frequency of APP, PSEN1, PSEN2, GRN and MAPT mutation in a well‐characterized series of late‐onset Alzheimer families
Chakraverty, Sumi, Mayo, Kevin, Robi, Mitra D., Bird, T., Diaz-Arrestia, Ramón, Bradley, Boeve, Graff‐Radford, Neill R. , Mayeux, Richard , Cruchaga, Carlos , Haller, Gabe , Vallania, Francesco , Robi, Mitra D, Boeve, Bradley F. , Goate, Alison

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2010.05.615 Get It

P1‐058: Association of glyceraldehyde‐3‐phosphate dehydrogenase locus variant with late‐onset Alzheimer's disease
Allen, Mariet , Cox, Claire , Bisceglio, Gina, Wilcox, Samantha L., Howell, Chanley C., Hunter, Talisha A., Culley, Oliver J. , Walker, Louise P., Carrasquillo, Minerva M. , Petersen, Ronald C. , Graff‐Radford, Neill R. , Younkin, Steven G., Ertekin‐Taner, Nilüfer , Belbin, Olivia , Ma, Li , Carrasquillo, Minerva M. , Dickson, Dennis W.

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2010.05.606 Get It

O4‐06‐05: Association of Aβ42, Aβ40 and Aβ2/Aβ40 with cognitive impairment not demented (CIND) and dementia in persons of mexican ancestry (SALSA study): Different for diabetics versus non‐diabetics?
Graff‐Radford, Neill R. , Lucas, John A. , Younkin, Linda H., Nah, Gregory , Younkin, Steven G., Haan, Mary N. , Crook, Julia E.

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2010.05.500 Get It

Off-Label Medication Use in Frontotemporal Dementia
Hu, Bei , Ross, Leslie , Kramer, Joel H. , Caselli, Richard J. , Graff‐Radford, Neill R. , Mendez, Mario F. , Boxer, Adam L. , Neuhaus, John M , Knopman, David S. , Boeve, Bradley F. , Miller, Bruce L. , Hu, Bei

American Journal of Alzheimer's Disease & Other Dementias® | February 1, 2010 | Volume: 25 | Issue: 2 | Pages: 128-133

10.1177/1533317509356692 Get It

Objective: There are no Food and Drug Administration (FDA)-approved medications indicated for the treatment of frontotemporal dementia (FTD). We sought to determine the most commonly used drugs used to treat behavioral variant FTD (bvFTD) in specialized dementia clinics. Methods: Medication and demographic data from the Alzheimer’s Disease Research Centers of California (ARCC) and a multicenter FTD natural history study (NHS) data set were compared in bvFTD and Alzheimer’s disease (AD), and effects of demographic variables were assessed using logistic regression. Results: Overall, the percentage of patients taking one or more FDA-approved AD or psychiatric medications was similar in bvFTD and AD; however, after controlling for demographic variables, acetylcholinesterase inhibitor (AChI) use was less common in bvFTD, whereas memantine use remained similar in the 2 groups. Conclusions: Despite lack of evidence for efficacy, the use of AChIs and memantine is common in bvFTD. Clinical trials should be pursued to determine the optimal therapeutic interventions for bvFTD.
P4‐128: Association of a missense cathepsin D (CTSD) SNP with risk of Alzheimer's disease
Younkin, Linda H., Reinstatler, Lael , Peterson, Ronald C. , Graff‐Radford, Neill R. , Younkin, Steven G. , Ertekin‐Taner, Nilüfer , Burgess, Jeremy D. , Leissring, Malcolm A. , Ma, Li , Crook, Julia E. , Pankratz, V. Shane , Dickson, Dennis W.

Alzheimer's & Dementia | June 25, 2009 | Volume: 5 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2009.04.796 Get It